Assessment of Feeding Tolerance in Infants Fed Cow Milk Formula

NCT ID: NCT00666120

Last Updated: 2008-04-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

333 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-06-30

Study Completion Date

2006-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the number of infants who discontinue from study formula due to formula intolerance as documented by the investigator.

Hypothesize there will be no difference between formula groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Term Infants Solely Formula Fed

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Cow's milk based infant formula

Group Type ACTIVE_COMPARATOR

Enfamil LIPIL with iron

Intervention Type OTHER

cow's milk based infant formula

2

Partially hydrolyzed cow's milk based infant formula

Group Type ACTIVE_COMPARATOR

Good Start Supreme with DHA and ARA

Intervention Type OTHER

partially hydrolzed cow's milk protein

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enfamil LIPIL with iron

cow's milk based infant formula

Intervention Type OTHER

Good Start Supreme with DHA and ARA

partially hydrolzed cow's milk protein

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Singleton birth
* Term infant at birth
* Birth weight of 2500 g (5 lbs 8 oz) or more
* 4 - 18 days of age at Study Visit 1

Exclusion Criteria

* History of underlying metabolic or chronic disease or congenital malformation
* Infant switched formulas more than one time between birth and Study Visit 1
* Known feeding problems at Study Visit 1
Minimum Eligible Age

4 Days

Maximum Eligible Age

18 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mead Johnson Nutrition

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mead Johnson

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carol Berseth, MD

Role: STUDY_DIRECTOR

Mead Johnson Nutrition

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Harvey Pediatrics

Jonesboro, Arkansas, United States

Site Status

Mercy Rogers Pediatric Clinic

Rogers, Arkansas, United States

Site Status

Lovelace Scientific Resources

Santa Ana, California, United States

Site Status

Tampa Bay Medical Research

Clearwater, Florida, United States

Site Status

Children's Medical Association

Tamarac, Florida, United States

Site Status

Children's Health Care

DeKalb, Illinois, United States

Site Status

Welborn Clinic

Evansville, Indiana, United States

Site Status

Fomon Infant Nutrition Unit

Iowa City, Iowa, United States

Site Status

Heartland Research Associates

Wichita, Kansas, United States

Site Status

Pediatrics Clinical Trials Unit

Louisville, Kentucky, United States

Site Status

Pedia Research

Owensboro, Kentucky, United States

Site Status

Arklatex Children's Center

Bossier City, Louisiana, United States

Site Status

Craig Spiegel, MD

Bridgeton, Missouri, United States

Site Status

The Center for Human Nutrition

Omaha, Nebraska, United States

Site Status

Boystown

Omaha, Nebraska, United States

Site Status

Winthrop Pediatric Associates

Mineola, New York, United States

Site Status

Cary Pediatric Center

Cary, North Carolina, United States

Site Status

Collom and Carney Clinic

Texarkana, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Berseth CL, Mitmesser SH, Ziegler EE, Marunycz JD, Vanderhoof J. Tolerance of a standard intact protein formula versus a partially hydrolyzed formula in healthy, term infants. Nutr J. 2009 Jun 19;8:27. doi: 10.1186/1475-2891-8-27.

Reference Type DERIVED
PMID: 19545360 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3370-6

Identifier Type: -

Identifier Source: org_study_id